Over-allotment option exercise
Company: CoreWeave
The claim, verbatim
Underwriters exercised portion of over-allotment option in April 2025, purchasing 1,760,000 additional shares at IPO price for net proceeds of $68 million
Source (primary)
CoreWeave 10-Q filed 2025-08-13 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “In April 2025, the underwriters exercised a portion of their over-allotment option and purchased from us an additional 1,760,000 shares of Class A common stock at the IPO price, which resulted in net proceeds to us of $68 million after deducting the underwriting discounts and commissions.”
How we checked this
Checked on September 17, 2026. The cited source supports every part of this claim.
The 10-Q describes the April 2025 partial over-allotment exercise of 1,760,000 shares at the IPO price. It states that this exercise produced $68 million in net proceeds.
Confirmed in the source:
- The underwriters exercised a portion of their over-allotment option in April 2025
- They purchased 1,760,000 additional shares at the IPO price
- The net proceeds were $68 million
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1769628/000176962825000041/crwv-20250630.htm) in full (481,765 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms CoreWeave 10-Q filed 2025-08-13
Quote: “In April 2025, the underwriters exercised a portion of their over-allotment option and purchased from us an additional 1,760,000 shares of Class A common stock at the IPO price, which resulted in net proceeds to us of $68 million after deducting the underwriting discounts and commissions.”